NetworkNewsBreaks – PreveCeutical Medical Inc. (
Post# of 77
(Total Views: 438)
Posted On: 08/15/2018 4:58:02 PM
NetworkNewsBreaks – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Inks Licensing Agreement with Asterion Cannabis; Engages Monster Media to Provide IR Services
Health sciences company PreveCeutical Medical (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) this morning announced that it has signed an agreement with Asterion Cannabis Inc. to acquire a worldwide license to use, manufacture, distribute and sell three Health Canada approved natural health products. Per the terms of the licensing agreement, Asterion has granted PreveCeutical a non-exclusive license to use Asterion’s intellectual property to make or have made, use, distribute, sell, offer to sell and promote the products in exchange for a royalty fee payable to Asterion equaling 20% of the gross sales. The licensing agreement’s initial term is five years and is renewable for five consecutive one-year terms. In addition, PreveCeutical also announced its entrance into an agreement with Monster Media, LLC for investor relations (“IR”) services. Per the terms of the IR agreement, Monster Media will provide investor relations and marketing services to the company for a period of three months, at which time PreveCeutical has the option to renew for subsequent three-month terms. Among other marketing tools, Monster Media will host and display advertorial content supplied by the company. PreveCeutical has paid Monster Media a one-time marketing fee of $50,000 and will pay a monthly hosting fee of $2,000.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Health sciences company PreveCeutical Medical (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) this morning announced that it has signed an agreement with Asterion Cannabis Inc. to acquire a worldwide license to use, manufacture, distribute and sell three Health Canada approved natural health products. Per the terms of the licensing agreement, Asterion has granted PreveCeutical a non-exclusive license to use Asterion’s intellectual property to make or have made, use, distribute, sell, offer to sell and promote the products in exchange for a royalty fee payable to Asterion equaling 20% of the gross sales. The licensing agreement’s initial term is five years and is renewable for five consecutive one-year terms. In addition, PreveCeutical also announced its entrance into an agreement with Monster Media, LLC for investor relations (“IR”) services. Per the terms of the IR agreement, Monster Media will provide investor relations and marketing services to the company for a period of three months, at which time PreveCeutical has the option to renew for subsequent three-month terms. Among other marketing tools, Monster Media will host and display advertorial content supplied by the company. PreveCeutical has paid Monster Media a one-time marketing fee of $50,000 and will pay a monthly hosting fee of $2,000.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)